Celltex therapeutics receives another fda approval: phase ii clinical trial using mesenchymal stem cells (mscs) as a prophylactic against covid-19

Celltex received approval from fda to proceed with phase ii clinical trial using mesenchymal stem cells (mscs) as a prophylactic against covid-19

MUX Ratings Summary

MUX Quant Ranking